Physician profile
Elizabeth E Andes
NPI 1811250038
$1,043.62
in general payments reported to CMS, 2019-2025
16 companies · $438 in 2025
The $438 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.74 · 2021: $12.71 · 2022: $17.44 · 2023: $226 · 2024: $265 · 2025: $438.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $928.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $269.20 | 2023-2025 | Injectafer |
| Astellas Pharma US INC | $254.09 | 2023-2025 | Veozah |
| Abbvie INC. | $105.73 | 2019-2023 | Lo Loestrin Fe |
| Sage Therapeutics, LLC | $92.18 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $62.52 | 2024-2025 | Myfembree |
| Exeltis, USA INC. | $45.00 | 2024-2025 | Slynd |
| Shield Therapeutics INC | $35.85 | 2025 | |
| Exact Sciences Corporation | $24.98 | 2025 | Cologuard Collection Kit |
| Organon LLC | $22.61 | 2025 | Nexplanon |
| Bayer Healthcare Pharmaceuticals INC. | $22.24 | 2023 | |
| Evofem Biosciences, INC. | $21.44 | 2025 | Phexxi, Solosec, Phexx |
| Supernus Pharmaceuticals, INC. | $20.99 | 2025 | Qelbree |
| Coopersurgical, INC. | $20.31 | 2024 | Paragard T 380a |
| Pfizer INC. | $17.44 | 2022 | |
| Hologic Sales and Service, LLC | $16.33 | 2024 | Aptima |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Andes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.